Skip to main content

Weitzman Deborah's Form 4 filing

Cardinal Health Inc (CAH) · filed Nov 29, 2023

Accession no.
0000721371-23-000112
Filed
Nov 29, 2023
Trade date
Nov 27, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.90M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Weitzman DeborahCIK 0001942639Officer (CEO, Pharmaceutical Segment)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 27, 2023Common SharesMOption exerciseAcquired+5,990$84.27+$504,777.350,192Direct
Nov 27, 2023Common SharesMOption exerciseAcquired+6,279$83.19+$522,350.0156,471Direct
Nov 27, 2023Common SharesMOption exerciseAcquired+15,373$66.43+$1,021,228.3971,844Direct
Nov 27, 2023Common SharesSSaleDisposed−36,642$106.31−$3,895,411.0235,202Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 27, 2023Common SharesMOption exerciseDisposed−5,990$0.00$00Direct
Nov 27, 2023Common SharesMOption exerciseDisposed−6,279$0.00$00Direct
Nov 27, 2023Common SharesMOption exerciseDisposed−15,373$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)